NCT01391533View on ClinicalTrials.gov

Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Malignant Solid Tumors
Interventions
DRUG

SAR125844

"Pharmaceutical form:solution~Route of administration: intravenous"

Trial Locations (8)

20133

Investigational Site Number 380002, Milan

20141

Investigational Site Number 380001, Milan

21079

Investigational Site Number 250002, Dijon

28040

Investigational Site Number 724003, Madrid

40138

Investigational Site Number 380004, Bologna

94805

Investigational Site Number 250001, Villejuif

02114

Investigational Site Number 840001, Boston

08035

Investigational Site Number 724001, Barcelona

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01391533 - Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors | Biotech Hunter | Biotech Hunter